Cargando…

HGprt deficiency disrupts dopaminergic circuit development in a genetic mouse model of Lesch–Nyhan disease

In Lesch–Nyhan disease (LND), deficiency of the purine salvage enzyme hypoxanthine guanine phosphoribosyl transferase (HGprt) leads to a characteristic neurobehavioral phenotype dominated by dystonia, cognitive deficits and incapacitating self-injurious behavior. It has been known for decades that L...

Descripción completa

Detalles Bibliográficos
Autores principales: Witteveen, J. S., Loopstok, S. R., Ballesteros, L. Luque, Boonstra, A., van Bakel, N. H. M., van Boekel, W. H. P., Martens, G. J. M., Visser, J. E., Kolk, S. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9167210/
https://www.ncbi.nlm.nih.gov/pubmed/35660973
http://dx.doi.org/10.1007/s00018-022-04326-x
_version_ 1784720777454551040
author Witteveen, J. S.
Loopstok, S. R.
Ballesteros, L. Luque
Boonstra, A.
van Bakel, N. H. M.
van Boekel, W. H. P.
Martens, G. J. M.
Visser, J. E.
Kolk, S. M.
author_facet Witteveen, J. S.
Loopstok, S. R.
Ballesteros, L. Luque
Boonstra, A.
van Bakel, N. H. M.
van Boekel, W. H. P.
Martens, G. J. M.
Visser, J. E.
Kolk, S. M.
author_sort Witteveen, J. S.
collection PubMed
description In Lesch–Nyhan disease (LND), deficiency of the purine salvage enzyme hypoxanthine guanine phosphoribosyl transferase (HGprt) leads to a characteristic neurobehavioral phenotype dominated by dystonia, cognitive deficits and incapacitating self-injurious behavior. It has been known for decades that LND is associated with dysfunction of midbrain dopamine neurons, without overt structural brain abnormalities. Emerging post mortem and in vitro evidence supports the hypothesis that the dopaminergic dysfunction in LND is of developmental origin, but specific pathogenic mechanisms have not been revealed. In the current study, HGprt deficiency causes specific neurodevelopmental abnormalities in mice during embryogenesis, particularly affecting proliferation and migration of developing midbrain dopamine (mDA) neurons. In mutant embryos at E14.5, proliferation was increased, accompanied by a decrease in cell cycle exit and the distribution and orientation of dividing cells suggested a premature deviation from their migratory route. An abnormally structured radial glia-like scaffold supporting this mDA neuronal migration might lie at the basis of these abnormalities. Consequently, these abnormalities were associated with an increase in area occupied by TH(+) cells and an abnormal mDA subpopulation organization at E18.5. Finally, dopaminergic innervation was disorganized in prefrontal and decreased in HGprt deficient primary motor and somatosensory cortices. These data provide direct in vivo evidence for a neurodevelopmental nature of the brain disorder in LND. Future studies should not only focus the specific molecular mechanisms underlying the reported neurodevelopmental abnormalities, but also on optimal timing of therapeutic interventions to rescue the DA neuron defects, which may also be relevant for other neurodevelopmental disorders. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00018-022-04326-x.
format Online
Article
Text
id pubmed-9167210
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-91672102022-06-06 HGprt deficiency disrupts dopaminergic circuit development in a genetic mouse model of Lesch–Nyhan disease Witteveen, J. S. Loopstok, S. R. Ballesteros, L. Luque Boonstra, A. van Bakel, N. H. M. van Boekel, W. H. P. Martens, G. J. M. Visser, J. E. Kolk, S. M. Cell Mol Life Sci Original Article In Lesch–Nyhan disease (LND), deficiency of the purine salvage enzyme hypoxanthine guanine phosphoribosyl transferase (HGprt) leads to a characteristic neurobehavioral phenotype dominated by dystonia, cognitive deficits and incapacitating self-injurious behavior. It has been known for decades that LND is associated with dysfunction of midbrain dopamine neurons, without overt structural brain abnormalities. Emerging post mortem and in vitro evidence supports the hypothesis that the dopaminergic dysfunction in LND is of developmental origin, but specific pathogenic mechanisms have not been revealed. In the current study, HGprt deficiency causes specific neurodevelopmental abnormalities in mice during embryogenesis, particularly affecting proliferation and migration of developing midbrain dopamine (mDA) neurons. In mutant embryos at E14.5, proliferation was increased, accompanied by a decrease in cell cycle exit and the distribution and orientation of dividing cells suggested a premature deviation from their migratory route. An abnormally structured radial glia-like scaffold supporting this mDA neuronal migration might lie at the basis of these abnormalities. Consequently, these abnormalities were associated with an increase in area occupied by TH(+) cells and an abnormal mDA subpopulation organization at E18.5. Finally, dopaminergic innervation was disorganized in prefrontal and decreased in HGprt deficient primary motor and somatosensory cortices. These data provide direct in vivo evidence for a neurodevelopmental nature of the brain disorder in LND. Future studies should not only focus the specific molecular mechanisms underlying the reported neurodevelopmental abnormalities, but also on optimal timing of therapeutic interventions to rescue the DA neuron defects, which may also be relevant for other neurodevelopmental disorders. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00018-022-04326-x. Springer International Publishing 2022-06-04 2022 /pmc/articles/PMC9167210/ /pubmed/35660973 http://dx.doi.org/10.1007/s00018-022-04326-x Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article
Witteveen, J. S.
Loopstok, S. R.
Ballesteros, L. Luque
Boonstra, A.
van Bakel, N. H. M.
van Boekel, W. H. P.
Martens, G. J. M.
Visser, J. E.
Kolk, S. M.
HGprt deficiency disrupts dopaminergic circuit development in a genetic mouse model of Lesch–Nyhan disease
title HGprt deficiency disrupts dopaminergic circuit development in a genetic mouse model of Lesch–Nyhan disease
title_full HGprt deficiency disrupts dopaminergic circuit development in a genetic mouse model of Lesch–Nyhan disease
title_fullStr HGprt deficiency disrupts dopaminergic circuit development in a genetic mouse model of Lesch–Nyhan disease
title_full_unstemmed HGprt deficiency disrupts dopaminergic circuit development in a genetic mouse model of Lesch–Nyhan disease
title_short HGprt deficiency disrupts dopaminergic circuit development in a genetic mouse model of Lesch–Nyhan disease
title_sort hgprt deficiency disrupts dopaminergic circuit development in a genetic mouse model of lesch–nyhan disease
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9167210/
https://www.ncbi.nlm.nih.gov/pubmed/35660973
http://dx.doi.org/10.1007/s00018-022-04326-x
work_keys_str_mv AT witteveenjs hgprtdeficiencydisruptsdopaminergiccircuitdevelopmentinageneticmousemodelofleschnyhandisease
AT loopstoksr hgprtdeficiencydisruptsdopaminergiccircuitdevelopmentinageneticmousemodelofleschnyhandisease
AT ballesteroslluque hgprtdeficiencydisruptsdopaminergiccircuitdevelopmentinageneticmousemodelofleschnyhandisease
AT boonstraa hgprtdeficiencydisruptsdopaminergiccircuitdevelopmentinageneticmousemodelofleschnyhandisease
AT vanbakelnhm hgprtdeficiencydisruptsdopaminergiccircuitdevelopmentinageneticmousemodelofleschnyhandisease
AT vanboekelwhp hgprtdeficiencydisruptsdopaminergiccircuitdevelopmentinageneticmousemodelofleschnyhandisease
AT martensgjm hgprtdeficiencydisruptsdopaminergiccircuitdevelopmentinageneticmousemodelofleschnyhandisease
AT visserje hgprtdeficiencydisruptsdopaminergiccircuitdevelopmentinageneticmousemodelofleschnyhandisease
AT kolksm hgprtdeficiencydisruptsdopaminergiccircuitdevelopmentinageneticmousemodelofleschnyhandisease